|
| Exchange Disseminated Time 11/04/2016 11:27:07 | | Orchid Pharma Ltd has informed BSE that Orchid received the Establishment inspection report (EIR) from USFDA based on the successful inspection closure for the API manufacturing facility located at Alathur, Kancheepuram District, India. The facility was inspected by USFDA in the month of August 2015. |
|
|